{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06223048",
            "orgStudyIdInfo": {
                "id": "AMDX-2011P-202"
            },
            "organization": {
                "fullName": "Amydis Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study of AMDX-2011P in Participants With Primary Open Angle Glaucoma",
            "officialTitle": "A Phase 2, Randomized, Open Label Study of AMDX-2011P as a Retinal Tracer in Participants With Primary Open Angle Glaucoma",
            "therapeuticArea": [
                "Ophthalmology"
            ],
            "study": "a-study-of-amdx-in-participants-with-primary-open-angle-glaucoma"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-12-07",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-11",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-02",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-12-14",
            "studyFirstSubmitQcDate": "2024-01-23",
            "studyFirstPostDateStruct": {
                "date": "2024-01-25",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-29",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-30",
                "type": "ESTIMATED"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Amydis Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this research study is to assess the ability of AMDX- 2011P to identify amyloid deposits in the retina of participants with Primary Open Angle Glaucoma (POAG).",
            "detailedDescription": "This open-label, masked endpoint assessment study will evaluate safety, tolerability, plasma pharmacokinetics (PK) and biological activity of intravenous (IV) doses of AMDX-2011P in participants with POAG. Assessments of retinal images will be conducted by centrally masked assessors.\n\nParticipants will be admitted to the study site where eye examination and retinal imaging will be conducted before administration of the study drug. AMDX-2011P will be administered through a single IV bolus injection followed by safety assessments, retinal imaging, and blood collection and PK."
        },
        "conditionsModule": {
            "conditions": [
                "Primary Open Angle Glaucoma"
            ],
            "keywords": [
                "POAG"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "interventionModelDescription": "Phase 2, randomized, parallel arm, open-label, masked endpoint study",
                "primaryPurpose": "DIAGNOSTIC",
                "maskingInfo": {
                    "masking": "SINGLE",
                    "whoMasked": [
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 50,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "AMDX-2011P 50 mg",
                    "type": "EXPERIMENTAL",
                    "description": "AMDX2011P mg 50 (2ml) single bolus injection intravenous for diagnostic review",
                    "interventionNames": [
                        "Drug: AMDX-2011P"
                    ]
                },
                {
                    "label": "AMDX-2011P 100 mg",
                    "type": "EXPERIMENTAL",
                    "description": "AMDX2011P 100mg (4ml) single bolus injection intravenous for diagnostic review",
                    "interventionNames": [
                        "Drug: AMDX-2011P"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "AMDX-2011P",
                    "description": "AMDX-2011P single bolus injection intravenous for diagnostic review",
                    "armGroupLabels": [
                        "AMDX-2011P 100 mg",
                        "AMDX-2011P 50 mg"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "AMDX-2011P Adverse Events Profile",
                    "description": "Incidence, nature and severity of AEs/SAEs",
                    "timeFrame": "8 days"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Concentration of AMDX-2011P",
                    "description": "Plasma PK Concentration (CMax)",
                    "timeFrame": "2 hours"
                },
                {
                    "measure": "Pharmacokinetic Analysis of AMDX-2011P",
                    "description": "Area under the plasma versus time curve (AUC)",
                    "timeFrame": "2 hours"
                },
                {
                    "measure": "Biological Activity",
                    "description": "Detection of amyloid deposits in the retina after intravenous AMDX-2011P administration using a conventional retinal fundus fluorescence imaging device.",
                    "timeFrame": "1 day"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Diagnosis of primary open angle glaucoma in both eyes\n2. Able to fixate\n3. Glaucomatous optic nerve damage in both eyes, as determined by an investigator as part of an eye exam\n\nExclusion Criteria:\n\n1. Participants unable to read or write\n2. Ocular media is not sufficiently clear to obtain acceptable quality images\n3. Participants with presence of any ocular pathology other than glaucoma in the study eye (cataracts are acceptable)",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "22 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Joyce Simpauco",
                    "role": "CONTACT",
                    "phone": "858-254-7435",
                    "email": "joyce@amydis.com"
                },
                {
                    "name": "David Bingaman",
                    "role": "CONTACT",
                    "email": "david.bingaman@amydis.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "David Bingaman",
                    "affiliation": "Amydis Inc.",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Associated Retina Consultants",
                    "status": "RECRUITING",
                    "city": "Phoenix",
                    "state": "Arizona",
                    "zip": "85020",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Mallory Mintert",
                            "role": "CONTACT",
                            "email": "mallory.mintert@doctrials.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.44838,
                        "lon": -112.07404
                    }
                },
                {
                    "facility": "Global Research Management",
                    "status": "RECRUITING",
                    "city": "Glendale",
                    "state": "California",
                    "zip": "91204",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Logi El-Harazi",
                            "role": "CONTACT",
                            "email": "logi@grmclinical.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.14251,
                        "lon": -118.25508
                    }
                },
                {
                    "facility": "Eye Research Foundation",
                    "status": "RECRUITING",
                    "city": "Newport Beach",
                    "state": "California",
                    "zip": "92663",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Linda Wirta",
                            "role": "CONTACT",
                            "email": "linda.wirta@drwirta.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.61891,
                        "lon": -117.92895
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000005901",
                    "term": "Glaucoma"
                },
                {
                    "id": "D000005902",
                    "term": "Glaucoma, Open-Angle"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009798",
                    "term": "Ocular Hypertension"
                },
                {
                    "id": "D000005128",
                    "term": "Eye Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M9013",
                    "name": "Glaucoma",
                    "asFound": "Glaucoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9014",
                    "name": "Glaucoma, Open-Angle",
                    "asFound": "Primary Open Angle Glaucoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10024",
                    "name": "Hypertension",
                    "relevance": "LOW"
                },
                {
                    "id": "M12731",
                    "name": "Ocular Hypertension",
                    "relevance": "LOW"
                },
                {
                    "id": "M8271",
                    "name": "Eye Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC11",
                    "name": "Eye Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                }
            ]
        }
    },
    "hasResults": false
}